These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6292311)

  • 1. Impairment of immunocompetent mouse spleen cell functions by infection with coxsackievirus B3.
    Bendinelli M; Matteucci D; Toniolo A; Patanè AM; Pistillo MP
    J Infect Dis; 1982 Dec; 146(6):797-805. PubMed ID: 6292311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lymphoid atrophy in coxsackievirus B3-infected mice: effects of virus and immunopotentiating agents.
    Matteucci D; Toniolo A; Conaldi PG; Basolo F; Gori Z; Bendinelli M
    J Infect Dis; 1985 Jun; 151(6):1100-8. PubMed ID: 2987368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Coxsackie A13 and B3 virus infections on the primary immune response to sheep erythrocytes].
    Shestenko OP; Bocharov EF
    Vopr Virusol; 1988; 33(2):235-9. PubMed ID: 2842965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of B lymphocytes in coxsackievirus B3 infection.
    Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
    Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological mechanisms in the pathogenesis of coxsackievirus infection].
    Bocharov EF; Shestenko OP
    Vopr Virusol; 1984; 29(5):516-21. PubMed ID: 6151318
    [No Abstract]   [Full Text] [Related]  

  • 8. Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes.
    Huber SA; Job LP; Woodruff JF
    Am J Pathol; 1980 Mar; 98(3):681-94. PubMed ID: 6244737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease.
    Hashimoto I; Tatsumi M; Nakagawa M
    Br J Exp Pathol; 1983 Oct; 64(5):497-504. PubMed ID: 6315043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
    Friedman H; Kateley JR
    Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
    Huber SA; Feldman AM; Sartini D
    Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium berghei: lymphocyte and macrophage dynamics in the spleen of Balb/c mice in the course of infection and after rechallenge of cured mice.
    Gross A; Geva S; Frankenburg S
    Exp Parasitol; 1988 Feb; 65(1):50-60. PubMed ID: 2962882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
    Huber S; Song WC; Sartini D
    Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.
    Jarasch-Althof N; Wiesener N; Schmidtke M; Wutzler P; Henke A
    Viral Immunol; 2010 Aug; 23(4):369-76. PubMed ID: 20712481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3.
    Estrin M; Smith C; Huber S
    Am J Pathol; 1986 Dec; 125(3):578-84. PubMed ID: 2432792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coxsackievirus B3-induction of tumor necrosis factor and IL-6 of murine monocyte-macrophages].
    Sen Q; Xu Y; Jiang A; Zhang T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):170-3. PubMed ID: 15619829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3.
    Huber SA; Job LP
    Infect Immun; 1983 Mar; 39(3):1419-27. PubMed ID: 6301994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
    Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
    J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Th17 cells and regulatory T cells in Coxsackievirus B3-induced myocarditis.
    Xie Y; Chen R; Zhang X; Chen P; Liu X; Xie Y; Yu Y; Yang Y; Zou Y; Ge J; Chen H
    Virology; 2011 Dec; 421(1):78-84. PubMed ID: 21993400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-related differences in the pattern of coxsackievirus B-3-induced immune spleen cell cytotoxicity against virus-infected myofibers.
    Huber SA; Job LP; Woodruff JF
    Infect Immun; 1981 Apr; 32(1):68-73. PubMed ID: 6260687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.